PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31600634-7	2019	CONCLUSION: Ticagrelor, empagliflozin and tamoxifen may correct vascular reactivity defects, where modulation of vascular AMPK, eNOS, Ang-II, ET-1, P-selectin, VCAM-1 and MMP-2 underline their protective effects.	Ticagrelor	12-22	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	122-126	
31600634-6	2019	RESULTS: Ticagrelor, empagliflozin and tamoxifen significantly increased aorta tissue AMPK and eNOS and decreased Ang-II, ET-1, P-selectin, VCAM-1 and VIP levels compared with RA/DM-co-morbidity, coupled with improved acetylcholine vasorelaxation in vitro.	Ticagrelor	9-19	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	86-90